Advanced search
Publication Cover
Current Medical Research and Opinion Volume 20, 2004 - Issue 2
Submit an article Journal homepage
260
Views
70
CrossRef citations to date
0
Altmetric
Research Article

Hyperprolactinaemia and antipsychotic therapy in schizophrenia

Martina Hummer Department of Biological Psychiatry, Innsbruck University Clinics, Innsbruck, AustriaCorrespondence[email protected]
&
Johannes Huber Clinical Division of Gynaecology, Endocrinology and Reproductive Medicine, AKH, Vienna, Austria
Pages 189-197 | Accepted 30 Oct 2004, Published online: 14 Nov 2004

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (11)

Fahad D. Alosaimi, Ebtihaj O. Fallata, Mohammed Abalhassan, Abdulhadi Alhabbad, Nasser Alzain, Bandar Alhaddad & Mohammed Z. Alassiry. (2018) Prevalence and risk factors of hyperprolactinemia among patients with various psychiatric diagnoses and medications. International Journal of Psychiatry in Clinical Practice 22:4, pages 274-281.
Read now
Emanuel Schwarz, Johann Steiner, Paul C. Guest, Bernhard Bogerts & Sabine Bahn. (2015) Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain. The World Journal of Biological Psychiatry 16:1, pages 22-30.
Read now
Mary V. Seeman. (2011) Antipsychotic-induced amenorrhea. Journal of Mental Health 20:5, pages 484-491.
Read now
Peter Höfer, Fabian Friedrich, Benjamin Vyssoki, Christoph Spindelegger, Maria Schmook, Christian Barnas, Otto M. Lesch & Henriette Walter. (2010) Hyperprolactinaemia and acute psychosis: Prolactinoma or medication-induced phenomenon?. The World Journal of Biological Psychiatry 11:5, pages 759-761.
Read now
Atheir Abbas & Bryan L Roth. (2008) Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders. Expert Opinion on Pharmacotherapy 9:18, pages 3251-3259.
Read now
Shinsuke Matsuzaki & Masaya Tohyama. (2008) Regulation of pituitary adenylyl cyclase-activating polypeptide (PACAP, ADCYAP1: adenylyl cyclase-activating polypeptide 1) in the treatment of schizophrenia. Expert Opinion on Therapeutic Targets 12:9, pages 1097-1108.
Read now
Gunvant K Thaker. (2007) Schizophrenia endophenotypes as treatment targets. Expert Opinion on Therapeutic Targets 11:9, pages 1189-1206.
Read now
H. Knegtering, Marco Boks, Carl Blijd, Stynke Castelein, RobertJ. van den Bosch & Durk Wiersma. (2006) A Randomized Open-Label Comparison of the Impact of Olanzapine Versus Risperidone on Sexual Functioning. Journal of Sex & Marital Therapy 32:4, pages 315-326.
Read now
Chul Lee, Kuang-Hsien Wu, Hussain Habil, Yulia Dyachkova & Phil Lee. (2006) Treatment with olanzapine, risperidone or typical antipsychotic drugs in Asian patients with schizophrenia. Australian and New Zealand Journal of Psychiatry 40:5, pages 437-445.
Read now
Oliver D. Howes, Shubulade Smith & Kathy J. Aitchison. (2004) Comment on Hyperprolactinaemia and antipsychotic therapy in schizophrenia. Current Medical Research and Opinion 20:10, pages 1649-1649.
Read now
Pandurang M. Kulkarni, Eric S. Meadows, Sanjeev Ahuja & David Muram. (2004) Rationale for a non-inferiority clinical trial design focused on subpopulations. Current Medical Research and Opinion 20:10, pages 1641-1647.
Read now

Articles from other publishers (59)

Akari Nakamura‐Utsunomiya, Satoshi Goda, Seiichi Hayakawa, Sakata Sonoko, Ewout J. Hoorn, Anne Blanchard, Akiko Saito‐Hakoda, Haruna Kakimoto, Rumi Hachiya, Miki Kamimura, Rie Kawakita, Shinji Higuchi, Rika Fujimaru, Yoko Shirai, Daichi Miyaoka, Yuki Nagata, Yutaro Kishi, Aya Wada, Akari Mitsuboshi, Kayo Ozaki, Nagisa Komatsu, Hidetaka Niizuma, Junko Kanno, Ikuma Fujiwara, Yukihiro Hasegawa, Tohru Yorifuji, Wendy Brickman, Marie‐Christine Vantyghem, Kei Yamaguchi, Naoki Goshima & Takeshi Y. Hiyama. (2022) Identification of clinical factors related to antibody‐mediated immune response to the subfornical organ. Clinical Endocrinology 97:1, pages 72-80.
Crossref
Tahir Rahman, John M. Sahrmann, Margaret A. Olsen, Katelin B. Nickel, J. Phillip Miller, Cynthia Ma & Richard A. Grucza. (2022) Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs. Journal of Clinical Psychopharmacology 42:1, pages 7-16.
Crossref
Gerald Litwack. 2022. Human Biochemistry. Human Biochemistry 475 516 .
Shankun Zhao, Xiaolan Wang, Xie Qiang, Hui Wang, Jian He, Maolei Shen, Changjun Zheng & Ran Kang. (2020) Is There an Association Between Schizophrenia and Sexual Dysfunction in Both Sexes? A Systematic Review and Meta-Analysis. The Journal of Sexual Medicine 17:8, pages 1476-1488.
Crossref
Alexandre González-Rodríguez, Javier Labad & Mary V. Seeman. (2020) Antipsychotic-induced Hyperprolactinemia in aging populations: Prevalence, implications, prevention and management. Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, pages 109941.
Crossref
Srihari Gopal, Rosanne Lane, Isaac Nuamah, Margaret Copenhaver, Jaskaran Singh, David Hough, Mark Bach & Adam Savitz. (2017) Evaluation of Potentially Prolactin-Related Adverse Events and Sexual Maturation in Adolescents with Schizophrenia Treated with Paliperidone Extended-Release (ER) for 2 Years: A Post Hoc Analysis of an Open-Label Multicenter Study. CNS Drugs 31:9, pages 797-808.
Crossref
Chien-Yu Chen, Hsien-Yuan Lane & Chieh-Hsin Lin. (2016) Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences. Clinical Psychopharmacology and Neuroscience 14:3, pages 238-249.
Crossref
Erik Wibowo & Richard J. Wassersug. (2016) Multiple Orgasms in Men—What We Know So Far. Sexual Medicine Reviews 4:2, pages 136-148.
Crossref
Ju-Yeon Lee, Sung-Wan Kim, Yo-Han Lee, Hee-Ju Kang, Seon-Young Kim, Kyung-Yeol Bae, Jae-Min Kim, Il-Seon Shin & Jin-Sang Yoon. (2015) Factors associated with self-rated sexual function in Korean patients with schizophrenia receiving risperidone monotherapy. Human Psychopharmacology: Clinical and Experimental 30:6, pages 416-424.
Crossref
M. K. de Boer, S. Castelein, D. Wiersma, R. A. Schoevers & H. Knegtering. (2015) The Facts About Sexual (Dys)function in Schizophrenia: An Overview of Clinically Relevant Findings. Schizophrenia Bulletin 41:3, pages 674-686.
Crossref
Naveen K. Neradugomma, Satheesh Sainathan, Joaquina Baranda, Dharmalingam Subramaniam & Shrikant Anant. (2014) Role of Prolactin and Its Receptor in Colorectal Cancer. Current Colorectal Cancer Reports 10:4, pages 453-462.
Crossref
J. Peuskens, L. Pani, J. Detraux & M. De Hert. (2014) The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review. CNS Drugs.
Crossref
Mengxin Wang, Ruihua Hou, Jia Jian, Guolin Mi, Huimin Qiu, Bingyu Cao & Maoqin Tang. (2014) Effects of antipsychotics on bone mineral density and prolactin levels in patients with schizophrenia: a 12-month prospective study. Human Psychopharmacology: Clinical and Experimental 29:2, pages 183-189.
Crossref
Takashi Tsuboi, Robert R. Bies, Takefumi Suzuki, David C. Mamo, Bruce G. Pollock, Ariel Graff-Guerrero, Masaru Mimura & Hiroyuki Uchida. (2013) Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: Analysis of the CATIE data. Progress in Neuro-Psychopharmacology and Biological Psychiatry 45, pages 178-182.
Crossref
Elena Rubio-Abadal & Judith Usall. (2013) Hiperprolactinemia y tratamiento antipsicótico. Manifestaciones clínicas y manejo. Psiquiatría Biológica 20:3, pages 27-34.
Crossref
Susana Ochoa, David Suarez, Diego Novick, Belen Arranz, Mercedes Roca, Vicente Baño & Josep Maria Haro. (2013) Factors Predicting Hostility in Outpatients With Schizophrenia. Journal of Nervous & Mental Disease 201:6, pages 464-470.
Crossref
Jianguang Ji, Kristina Sundquist, Yi Ning, Kenneth S. Kendler, Jan Sundquist & Xiangning Chen. (2013) Incidence of Cancer in Patients With Schizophrenia and Their First-Degree Relatives: A Population-Based Study in Sweden. Schizophrenia Bulletin 39:3, pages 527-536.
Crossref
Haishan Wu, Lu Deng, Lipin Zhao, Jingping Zhao, Lehua Li & Jindong Chen. (2013) Osteoporosis Associated with Antipsychotic Treatment in Schizophrenia. International Journal of Endocrinology 2013, pages 1-7.
Crossref
Fatemeh Sheikhmoonesi & Seyyedeh Fatemeh Bahari Saravi. (2012) Deep venous thrombosis and atypical antipsychotics: three cases report. DARU Journal of Pharmaceutical Sciences 20:1.
Crossref
Khalid A. J. Al-Khaja, Reginald P. Sequeira, Mohammed K. Al-Haddad & Adel R. Al-Offi. (2012) Psychotropic Drug Prescribing Trends in Bahrain: Implications for Sexual Functions. International Journal of Clinical Medicine 03:04, pages 276-282.
Crossref
Zeynep Kotan, Berrin Ertepe, Cengiz Akkaya, Emre Sarandol, Güven Ozkaya & Selçuk Kirli. (2011) Metabolic, endocrinologic and cardiac effects of amisulpride: a 24-week follow-up study. Therapeutic Advances in Psychopharmacology 1:6, pages 189-196.
Crossref
Jayashri Kulkarni & Emmy Gavrilidis. (2012) Estrogen as an adjunctive treatment approach for managing schizophrenia. Psychiatrie und Psychotherapie 7:4, pages 124-128.
Crossref
Marrit K. de Boer, Durk Wiersma, Johan Bous, Sjoerd Sytema, Andrea E. G. M. van der Moolen, Bob Wilffert, Takashi Hamamura & Henderikus Knegtering. (2011) A Randomized Open-Label Comparison of the Impact of Aripiprazole Versus Risperidone on Sexual Functioning (RAS Study). Journal of Clinical Psychopharmacology 31:4, pages 523-525.
Crossref
Peter Malik, Georg Kemmler, Martina Hummer, Anita Riecher-Roessler, René S. Kahn & W. Wolfgang Fleischhacker. (2011) Sexual Dysfunction in First-Episode Schizophrenia Patients. Journal of Clinical Psychopharmacology 31:3, pages 274-280.
Crossref
Guy Goodwin, Wolfgang Fleischhacker, Celso Arango, Pierre Baumann, Michael Davidson, Marc de Hert, Peter Falkai, Shitij Kapur, Stefan Leucht, Rasmus Licht, Dieter Naber, Veronica O’Keane, George Papakostas, Eduard Vieta & Joseph Zohar. (2011) Ventajas y desventajas del tratamiento de combinación con antipsicóticos. Reunión ECNP Consensus, marzo de 2008, Niza. Psiquiatría Biológica 18:2, pages 55-67.
Crossref
Ahmed Mahmoud, Karen P. Hayhurst, Richard J. Drake & Shôn W. Lewis. (2011) Second Generation Antipsychotics Improve Sexual Dysfunction in Schizophrenia: A Randomised Controlled Trial. Schizophrenia Research and Treatment 2011, pages 1-6.
Crossref
Jenn-Huei Renn, Nan-Ping Yang & Pesus Chou. (2010) Effects of plasma magnesium and prolactin on quantitative ultrasound measurements of heel bone among schizophrenic patients. BMC Musculoskeletal Disorders 11:1.
Crossref
Vadim S. Rotenberg. (2017) Sexual Disorders Caused by Antidepressants: Considerations in the Context of Brain Hemisphere Functions. Activitas Nervosa Superior 52:2, pages 47-61.
Crossref
Sara Haack, Angela Seeringer, Petra A Thürmann, Thomas Becker & Julia Kirchheiner. (2009) Sex-specific differences in side effects of psychotropic drugs: genes or gender?. Pharmacogenomics 10:9, pages 1511-1526.
Crossref
C Akkaya, B Kaya, Z Kotan, A Sarandol, C Ersoy & S Kirli. (2008) Hyperprolactinemia and possibly related development of prolactinoma during amisulpride treatment; three cases. Journal of Psychopharmacology 23:6, pages 723-726.
Crossref
Diego Novick, Josep Maria Haro, Elena Perrin, David Suarez & Jo?o Marques Texeira. (2009) Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study. European Neuropsychopharmacology 19:8, pages 542-550.
Crossref
Guy Goodwin, Wolfgang Fleischhacker, Celso Arango, Pierre Baumann, Michael Davidson, Marc de Hert, Peter Falkai, Shitij Kapur, Stefan Leucht, Rasmus Licht, Dieter Naber, Veronica O'Keane, George Papakostas, Eduard Vieta & Joseph Zohar. (2009) Advantages and disadvantages of combination treatment with antipsychotics. European Neuropsychopharmacology 19:7, pages 520-532.
Crossref
Pierre Thomas, Köksal Alptekin, Mihai Gheorghe, Mauro Mauri, José Manuel Olivares & Michael Riedel. (2009) Management of Patients Presenting with Acute Psychotic Episodes of Schizophrenia. CNS Drugs 23:3, pages 193-212.
Crossref
Martin Lambert, W. Wolfgang Fleischhacker & Dieter Naber. 2009. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen 55 94 .
Linda Hanssens, Gilbert L'Italien, Jean-Yves Loze, Ronald N Marcus, Miranda Pans & Wendy Kerselaers. (2008) The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913). BMC Psychiatry 8:1.
Crossref
Jens Westheide, Gabriele Cvetanovska, Carsten Albrecht, Niclaas Bliesener, Déirdre Cooper‐Mahkorn, Cornelia Creutz, Wolfgang‐Peter Hornung, Dietrich Klingmüller, Matthias R. Lemke, Wolfgang Maier, Michaela Schubert, Birgitta Sträter & Kai‐Uwe Kühn. (2008) Prolactin, Subjective Well‐Being and Sexual Dysfunction: An Open Label Observational Study Comparing Quetiapine with Risperidone. The Journal of Sexual Medicine 5:12, pages 2816-2826.
Crossref
V. Regitz-Zagrosek, C. Schubert & S. Krüger. (2008) Geschlechterunterschiede in der neuropsychiatrischen PharmakotherapieGender differences in psychopharmacology. Der Internist 49:12, pages 1516-1523.
Crossref
N. Bergemann, P. Parzer, C. Mundt & B. Auler. (2008) High bone turnover but normal bone mineral density in women suffering from schizophrenia. Psychological Medicine 38:8, pages 1195-1201.
Crossref
Martin Baggaley. (2008) Sexual dysfunction in schizophrenia: focus on recent evidence. Human Psychopharmacology: Clinical and Experimental 23:3, pages 201-209.
Crossref
Radovan Mal?Ji?? Masopust, Ladislav Hos?k & Kate?ina Konup??kov?. (2008) Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients. Psychiatry and Clinical Neurosciences 62:1, pages 3-8.
Crossref
W. Wolfgang Fleischhacker, Martina Hummer & Alex Hofer. 2008. Handbuch der Psychopharmakotherapie. Handbuch der Psychopharmakotherapie 847 872 .
Lucas Lecourtier, Houman Homayoun, Gilles Tamagnan & Bita Moghaddam. (2007) Positive Allosteric Modulation of Metabotropic Glutamate 5 (mGlu5) Receptors Reverses N-Methyl-D-Aspartate Antagonist-Induced Alteration of Neuronal Firing in Prefrontal Cortex. Biological Psychiatry 62:7, pages 739-746.
Crossref
Peter Malik. (2007) Sexual dysfunction in schizophrenia. Current Opinion in Psychiatry 20:2, pages 138-142.
Crossref
Debbie Robson & Richard Gray. (2007) Serious mental illness and physical health problems: A discussion paper. International Journal of Nursing Studies 44:3, pages 457-466.
Crossref
Louise Howard, Graham Kirkwood & Morven Leese. (2018) Risk of hip fracture in patients with a history of schizophrenia. British Journal of Psychiatry 190:2, pages 129-134.
Crossref
W. Aichhorn, A. B. Whitworth, E. M. Weiss, H. Hinterhuber & J. Marksteiner. (2007) Neuere AntipsychotikaDifferences between men and women in side effects of second-generation antipsychotics. Der Nervenarzt 78:1, pages 45-52.
Crossref
W. W. Fleischhacker & M. Hummer. (2006) Pharmakotherapie der SchizophreniePharmacotherapy for schizophrenia. Der Nervenarzt 77:S03, pages S77-S98.
Crossref
Vincent Goffin, Philippe Touraine, Michael D Culler & Paul A Kelly. (2006) Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia?. Nature Clinical Practice Endocrinology & Metabolism 2:10, pages 571-581.
Crossref
Mikhail Kalinichev, Claire Rourke & Declan N.C. Jones. (2006) Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine. Behavioural Pharmacology 17:3, pages 289-292.
Crossref
Kevin F. Foley & Richard E. Kast. (2006) Review of evidence that posttransplantation psychiatric treatment commonly affects prolactin levels and thereby influences graft fate. General Hospital Psychiatry 28:3, pages 230-233.
Crossref
Julia Engl, Alexander Tschoner, Markus Laimer, Maria Rettenbacher, W. Wolfgang Fleischhacker, Josef R. Patsch & Christoph Ebenbichler. (2006) Metabolische Nebenwirkungen von Antipsychotika der neuen GenerationAntipsychotic drug-induced changes in metabolism. Wiener klinische Wochenschrift 118:7-8, pages 196-206.
Crossref
Wolfgang Aichhorn, Alexandra B Whitworth, Elisabeth M Weiss & Josef Marksteiner. (2006) Second-Generation Antipsychotics. Drug Safety 29:7, pages 587-598.
Crossref
Mikhail Kalinichev, Claire Rourke, Alex J. Daniels, Mary K. Grizzle, Christy S. Britt, Diane M. Ignar & Declan N. C. Jones. (2005) Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats. Psychopharmacology 182:2, pages 220-231.
Crossref
Tillmann H. C. Krüger, Uwe Hartmann & Manfred Schedlowski. (2005) Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World Journal of Urology 23:2, pages 130-138.
Crossref
Stephen J. Bartels. (2004) Caring for the Whole Person: Integrated Health Care for Older Adults with Severe Mental Illness and Medical Comorbidity. Journal of the American Geriatrics Society 52, pages S249-S257.
Crossref
Simeen Akhtar, Ciara Kelly, Andrew Gallagher & John R Petrie. (2016) Review: Newer antipsychotic agents, carbohydrate metabolism and cardiovascular risk. The British Journal of Diabetes & Vascular Disease 4:5, pages 303-309.
Crossref
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:6.
Crossref
Kate McKeage & Greg L Plosker. (2004) Amisulpride. CNS Drugs 18:13, pages 933-956.
Crossref
E. Rüther. 2004. Universitätskolloquien zur Schizophrenie. Universitätskolloquien zur Schizophrenie 471 481 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.